Statements (51)
Predicate | Object |
---|---|
gptkbp:instanceOf |
mental disorder
|
gptkbp:affects |
gptkb:Animalia
emotion perception thought |
gptkbp:alsoKnownAs |
schizophrenia
|
gptkbp:associatedWith |
impaired social functioning
dopamine dysregulation |
gptkbp:canBeChronic |
yes
|
gptkbp:canBeEpisodic |
yes
|
gptkbp:cause |
homelessness
disability increased suicide risk |
gptkbp:characterizedBy |
hallucinations
delusions emotional blunting disorganized thinking |
gptkbp:diagnosedBy |
gptkb:DSM-5_criteria
clinical assessment |
gptkbp:DSM-5_code |
295.xx
|
gptkbp:firstDescribed |
gptkb:Emil_Kraepelin
late 19th century |
gptkbp:hasCognitiveSymptoms |
impaired memory
impaired executive function impaired attention |
gptkbp:hasNegativeSymptoms |
gptkb:anhedonia
alogia avolition |
gptkbp:hasPositiveSymptoms |
hallucinations
delusions |
https://www.w3.org/2000/01/rdf-schema#label |
Disorders, Schizophrenic
|
gptkbp:ICD-10_code |
F20
|
gptkbp:onset |
early adulthood
late adolescence |
gptkbp:prevalence |
about 1% of population
|
gptkbp:prognosis |
variable
|
gptkbp:riskFactor |
genetic predisposition
cannabis use prenatal stress |
gptkbp:subspecies |
paranoid schizophrenia
catatonic schizophrenia disorganized schizophrenia residual schizophrenia undifferentiated schizophrenia |
gptkbp:symptom |
paranoia
cognitive impairment social withdrawal |
gptkbp:treatment |
gptkb:psychotherapy
antipsychotic medication |
gptkbp:bfsParent |
gptkb:D012852
|
gptkbp:bfsLayer |
7
|